About Amneal Pharmaceuticals, Inc. 
Amneal Pharmaceuticals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 59 Schemes (20.87%)
Foreign Institutions
Held by 120 Foreign Institutions (5.29%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
723 Million
(Quarterly Results - Mar 2026)
Net Profit:
78 Million
Pharmaceuticals & Biotechnology
USD 3,728 Million (Small Cap)
22.00
NA
0.00%
-32.15
-999,999.00%
-52.66






